Has There Been Any Progress in the X-ray Diagnosis and Differential Diagnosis of Inflammatory Bowel Disease?

1982 ◽  
pp. 107-115
Author(s):  
Mansho T. Khilnani
Keyword(s):  
Inflammatory Bowel Disease ◽  
Differential Diagnosis ◽  
Bowel Disease ◽  
X Ray ◽  
Inflammatory Bowel

scholarly journals Rational Use of Fecal Calprotectin in Irritable Bowel Syndrome and Inflammatory Bowel Disease

2021 ◽  
Author(s):  
Roberto Catanzaro ◽  
Alfio Maugeri ◽  
Morena Sciuto ◽  
Fang He ◽  
Baskar Balakrishnan ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Differential Diagnosis ◽  
Bowel Disease ◽  
Intestinal Inflammation ◽  
Gastrointestinal Disorder ◽  
Fecal Calprotectin ◽  
Mean Values ◽  
Inflammatory Bowel ◽  
Irritable Bowel

The gastrointestinal pathologies have increased over the last years. The clinical pictures of inflammatory and irritable bowel disease might overlap, leading to expensive and invasive tests. Our study aims to investigate fecal calprotectin as an effective tool for differential diagnosis of gastrointestinal disorders. Two hundred fifty-six patients with the diagnosis of the gastrointestinal disorder and subjected to colonoscopy were collected for the statistical analysis of fecal calprotectin. The differential diagnosis of intestinal inflammation or non-inflammation was performed according to the Receiver Operating Characteristic (ROC) curve that outlines the Area Under Curve (AUC), Sensitivity (Se), Specificity (Sp). Fecal calprotectin was significantly elevated in patients with inflammatory bowel disease compared with patients with irritable bowel syndrome. Especially, the mean values of fecal calprotectin were 522 g/g (IQR=215-975) and 21 g/g (IQR=14-34.5) in patients with and without inflammation, respectively (P<0.0001). AUC value of fecal calprotectin was 0.958 (Se=88.9%, Sp=91.1%, with a cut-off value of 50 g/g) for differentiating between inflammatory bowel disease and irritable bowel syndrome. Fecal calprotectin seems to be a non-invasive and inexpensive biomarker useful for the purpose of a differential diagnosis between inflammatory bowel disease and irritable bowel syndrome.

scholarly journals From Bowel inflammation to the Bone and Joints: Rheumatologic examination in Inflammatory Bowel Disease (IBD)

2021 ◽  
Author(s):  
Samane Tavassoli ◽  
Seyed Farzam Mirkamali ◽  
Iman Shahabinasab ◽  
Alireza Norouzi ◽  
Taghi Amiriani ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
New York ◽  
Bowel Disease ◽  
Musculoskeletal Symptoms ◽  
Low Back ◽  
X Ray ◽  
Wall Distance ◽  
Musculoskeletal Manifestations ◽  
Inflammatory Bowel ◽  
Grade 3

Abstract Background: The most common complications in inflammatory Bowel Disease (IBD) are musculoskeletal manifestations that are reported in more than 50% of patients. Objectives: In this study, we aimed to evaluate the musculoskeletal and radiologic manifestations in our IBD patients.Methods: In this study on 96 mild-to-moderate IBD patients (76 UC, 18 CD and 2 undifferentiated IBD) with mean (SD) age of 39.28 (11.42) years, 44 (45.8%) were males and 52 were (54.2%) females. Patients were examined by an expert rheumatologist and their musculoskeletal symptoms were assessed. The musculoskeletal system was evaluated by Modified Schober test, Thoracic expansion (TE), Occiput to wall distance (OWD), and Patrick's or FABER test. Peripheral joints were also examined in all four extremities. Then patients were referred for pelvic and lumbosacral x-ray. Sacroiliitis grading was performed using the New York criteria. Results: Inflammatory low back pain was reported in 5 (5.2%), enthesopathy in 6 (6.5%) and dactilitis in 1 (1.1%). Positive Schober test was recorded in 5 (5.2%) and Patrick test in 3 (3.1%). Forty-nine (51%) cases had normal imaging with no sacroilliitis, endplate sclerosis was seen in 33 cases (34.4%), grade 3 and grade 4 were seen in 10 cases (10.4%). Conclusions: In the present study, 34.4% of the IBD patients had mild radiologic changes as endplate sclerosis and 95% had a normal physical examination.

scholarly journals Nem minden coeliakia, ami annak látszik. Coeliakia és gyulladásos bélbetegség együttes előfordulása

2015 ◽  
Vol 156 (26) ◽  
pp. 1059-1064
Author(s):  
István Tokodi
Keyword(s):  
Inflammatory Bowel Disease ◽  
Differential Diagnosis ◽  
Celiac Disease ◽  
Coeliac Disease ◽  
Bowel Disease ◽  
Gene Polymorphisms ◽  
The Other ◽  
Pathophysiological Mechanism ◽  
History Of ◽  
Inflammatory Bowel

The prevalence of inflammatory bowel disease is ten times more common in patients with celiac disease; however, studies investigating the reverse relation have contradictory findings. Many gene polymorphisms are known to be present in both diseases; furthermore, similarities observed in their pathophysiological mechanism, their family concomitance, results of the serologic analysis and their macroscopic and microscopic symptoms in the gastro-intestinal system suggest a relevant association between the two diseases. The author presents the history of four patients, of whom two had both Crohn’s and coeliac diseases. In the two other patients with inflammatory bowel disease the possible diagnosis of coeliac disease was suspected, but after additional examinations coeliac disease was excluded in one patient and seemed to be unlikely in the other patient. The author concludes that the differential diagnosis of the two diseases is not easy and if one of them is diagnosed, the possible presence of the other one should be taken into consideration. Orv. Hetil., 2015, 156(26), 1059–1064.

scholarly journals Non-neoplastic colorectal disease biopsies: evaluation and differential diagnosis

2020 ◽  
Vol 73 (12) ◽  
pp. 783-792
Author(s):  
Michelle Moore ◽  
Roger M Feakins ◽  
Gregory Y Lauwers
Keyword(s):  
Inflammatory Bowel Disease ◽  
Differential Diagnosis ◽  
Bowel Disease ◽  
Host Response ◽  
Histological Diagnosis ◽  
Colorectal Disease ◽  
Pattern Of Injury ◽  
Immune Mediated ◽  
Methodical Approach ◽  
Inflammatory Bowel

A wide variety of non-neoplastic conditions may be encountered on colorectal biopsy encompassing idiopathic, infectious, vascular and immune-mediated aetiologies. Although interpretation of such biopsies may be challenging, appreciation of the dominant pattern of injury and subsequent host response may allow for a more focused histological diagnosis in the correct clinical and endoscopic setting. This article aims to provide a systematic, methodical approach to the assessment of such biopsies, concentrating mainly on diagnoses other than inflammatory bowel disease.

scholarly journals A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls

GastroHep ◽  
2020 ◽  
Vol 2 (5) ◽  
pp. 193-204
Author(s):  
Sara Ramió‐Pujol ◽  
Joan Amoedo ◽  
Mariona Serra‐Pagès ◽  
Leyanira Torrealba ◽  
Anna Bahí ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Differential Diagnosis ◽  
Bowel Disease ◽  
Healthy Controls ◽  
Inflammatory Bowel ◽  
Irritable Bowel
Sign in / Sign up

Export Citation Format

Share Document